MarketCap
Facebook
X
Telegram
Allied Healthcare Products Income Statement 2022-2008 | AHPI
Brief overview of profit and loss at Allied Healthcare Products
This overview is based on financial performance over the past five years. According to figures from Allied Healthcare Products, revenue changed from $8.7 million to $6 million over five years. The total change was −31%, with a CAGR of approximately −7.2%. The negative rate indicates weakening core operations.
Gross profit changed from $1.9 million to $443 thousand (−76.8%). Direct costs outpaced revenue, limiting the benefit of changes in sales. At the margin level, the figure shifted from 21.9% to 7.4%. The business retained less gross profit from each unit of revenue.
Over the period, EBITDA shifted from 846 thousand dollars to −815 thousand dollars, a change of −196.3%. Changes in revenue did not translate into comparable EBITDA performance. EBITDA margin moved from 9.7% to −13.5%. Cost pressure reduced operating profitability.
Net income moved from −381 thousand dollars at the start to −1.9 million dollars at the end. The loss widened and increased the financial risk.
Over the period, capitalization shifted from $8.4 million to $5.4 million (−35.9%). Lower capitalization reflects weaker investor expectations.
What the figures show
The financial trajectory is weak and requires a cautious interpretation. The overall view is constrained by a weaker market valuation, lower net income and limited operating profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.38 M | 23.4 M | 19.5 M | 4.9 M | 7.34 M | 8.39 M | 8.03 M | 8.99 M | 29.5 M | 36.8 M | 42.7 M | 55.1 M | - | - | - |
Shares |
4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 8.03 M | 8.07 M | 8.12 M | 8.11 M | 8.07 M | - | - |
Historical Prices |
1.34 | 5.82 | 4.87 | 1.22 | 1.83 | 2.09 | 2 | 2.24 | 3.68 | 4.56 | 5.26 | 6.8 | - | - | - |
Net Income |
-1.94 M | -1.16 M | 700 K | -1.53 M | -779 K | -381 K | -375 K | -709 K | -45 K | -899 K | -469 | 23 K | 117 K | - | - |
Revenue |
6.02 M | 6.81 M | 11.1 M | 7.31 M | 8.11 M | 8.72 M | 8.27 M | 35.5 M | 36.4 M | 38.6 M | 43.4 M | 46.8 M | - | - | - |
Cost of Revenue |
24.5 M | 29.2 M | 26.3 M | 26.3 M | 27.3 M | 27 M | 28.6 M | 28.4 M | 29.1 M | 30.3 M | 33.5 M | 35.8 M | 34.9 M | - | - |
Gross Profit |
443 K | 707 K | 2.61 M | 1.35 M | 1.2 M | 1.91 M | 1.7 M | 1.78 M | 2.16 M | 1.94 M | 2.11 K | 2.74 M | 2.81 M | - | - |
Operating Income |
-1.27 M | -1.13 M | 734 K | -1.51 M | -762 K | -244 K | -373 K | -688 K | -35 K | -892 K | -751 | 41 K | 209 K | - | - |
Interest Expense |
191 K | 116 K | 64.7 K | 56.2 K | 23.6 K | - | - | - | - | - | 336 | 66 | -4.27 K | - | - |
EBITDA |
-815 K | -551 K | 1.35 M | -690 K | 169 K | 846 K | 855 K | 623 K | 1.25 M | 414 K | 1.28 M | 1.4 M | 1.57 M | - | - |
Operating Expenses |
- | - | - | 7.81 M | 8.45 M | 8.61 M | 9.28 M | 8.76 M | 10.4 M | 10.7 M | 10.6 M | 10.6 M | - | - | - |
General and Administrative Expenses |
7.11 M | 7.64 M | 8.63 M | 7.81 M | 8.45 M | 8.61 M | 9.28 M | 8.76 M | 10.4 M | 10.7 M | 10.6 M | 10.6 M | 11.9 M | - | - |
All numbers in USD currency
Quarterly Income Statement Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 4.01 M | - | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 8.03 M | 4.01 M | 8.03 M | 8.03 M | 8.03 M | 4.01 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 8.1 M | 8.12 M | 8.1 M | 8.12 M | 8.12 M | 8.12 M | 8.12 M | 8.1 M | 8.12 M | 8.11 M |
Net Income |
- | -1.28 M | - | -1.28 M | -1.16 M | -413 K | -1.16 M | -984 K | 700 K | -330 K | -1.53 M | -153 K | -1.53 M | 378 K | -779 K | -1.23 M | -779 K | -901 K | -381 K | -767 K | -381 K | -403 K | -375 K | -816 K | -375 K | -784 K | -709 K | -530 K | -709 K | -503 K | -44.8 K | -708 K | -45 K | -969 K | -899 K | -591 K | -899 K | -279 K | -469 K | -411 K | -469 | -146 K | 22.7 K | -145 K | 23 K | -145 K | 22.7 K | -145 K |
Revenue |
- | 6.87 M | - | 6.87 M | 6.81 M | 7.97 M | 6.81 M | 7.36 M | 11.1 M | 8.1 M | 7.31 M | 10.2 M | 7.31 M | 8.32 M | 8.11 M | 7.27 M | 8.11 M | 7.27 M | 8.11 M | 8.47 M | 8.72 M | 7.9 M | 16.6 M | 8.58 M | 8.27 M | 8.44 M | 8.27 M | 8.44 M | 8.85 M | 8.46 M | 8.85 M | 8.46 M | 9 M | 8.84 M | 9 M | 8.85 M | 8.75 M | 8.71 M | 8.75 M | 8.71 M | 9.92 K | 9.29 K | 9.92 M | 9.29 M | 10.7 M | 11.4 M | 10.7 M | 11.4 M |
Cost of Revenue |
- | 6.43 M | - | 6.43 M | 6.1 M | 6.53 M | 6.1 M | 6.42 M | 8.49 M | 6.51 M | 5.96 M | 8.32 M | 5.96 M | 6.77 M | 6.9 M | 6.39 M | 6.9 M | 7.23 M | 6.81 M | 6.54 M | 6.81 M | 6.85 M | 6.57 M | 6.88 M | 6.57 M | 7.21 M | 7.07 M | 6.76 M | 7.07 M | 6.8 M | 6.84 M | 7.27 M | 6.84 M | 7.37 M | 6.81 M | 6.95 M | 6.81 M | 7.53 M | 7.82 M | 7.31 M | 7.82 M | 8.38 M | 7.95 M | 8.99 M | 7.95 M | 8.99 M | 7.95 M | 8.99 M |
Gross Profit |
- | 440 K | - | 440 K | 707 K | 1.44 M | 707 K | 937 K | 2.61 M | 1.59 M | 1.35 M | 1.87 M | 1.35 M | 1.55 M | 1.21 M | 879 K | 1.2 M | 1.23 M | 1.91 M | 1.36 M | 1.91 M | 1.74 M | 1.7 M | 1.56 M | 1.7 M | 1.63 M | 1.78 M | 1.7 M | 1.78 M | 1.7 M | 2.16 M | 1.57 M | 2.16 M | 1.75 M | 1.94 M | 1.76 M | 1.94 M | 1.68 M | 2.11 M | 1.98 M | 2.11 K | 2.33 M | 2.73 M | 2.41 M | 2.74 M | 2.41 M | 2.73 M | 2.41 M |
Operating Income |
- | -1.23 M | - | -1.23 M | -1.13 M | -381 K | -1.13 M | -952 K | 734 K | -305 K | -1.51 M | -135 K | -1.51 M | -353 K | -762 K | -1.23 M | -762 K | -888 K | -244 K | -767 K | -244 K | -403 K | -373 K | -817 K | -373 K | -762 K | -688 K | -635 K | -688 K | -489 K | -35 K | -698 K | -35 K | -960 K | -892 K | -862 K | -892 K | -960 K | -751 K | -660 K | -751 | -231 K | 41 K | -228 K | 41 K | -228 K | 41 K | -228 K |
Interest Expense |
- | 47.9 K | - | 47.9 K | 42 K | 32.2 K | 42 K | 31.7 K | 33.5 K | 25.8 K | 19 K | 18.2 K | 19 K | 18.6 K | 17.7 K | 8.29 K | 17.7 K | 13.4 K | -185 | -52 | - | -40 | -1.63 K | -39 | -1.63 K | -22.5 K | -21.9 K | -19.8 K | -21.9 K | -14.7 K | -10.5 K | -11.4 K | -10.5 K | -9.19 K | -8.76 K | -8.72 K | -8.76 K | -8.72 K | -8.76 K | - | - | - | - | -336 | - | -336 | - | -336 |
EBITDA |
- | -891 K | - | -1.23 M | -1.13 M | 72.8 K | -902 K | -840 K | 734 K | 158 K | -1.19 M | 29.2 K | -1.51 M | 283 K | -326 K | -1.01 M | -762 K | -184 K | 232 K | -527 K | -244 K | 439 K | 190 K | -534 K | -373 K | 177 K | -55.9 K | -317 K | -688 K | 499 K | 632 K | -363 K | -35 K | -13.4 K | -276 K | -557 K | -892 K | 31.3 K | -101 K | -352 K | -751 | 718 K | 668 K | 78.8 K | 41 K | 78.8 K | 668 K | 78.8 K |
General and Administrative Expenses |
- | 1.67 M | - | 1.67 M | 1.84 M | 1.82 M | 1.84 M | 1.89 M | 1.88 M | 1.89 M | 2.86 M | 2.01 M | 2.86 M | 1.9 M | 1.97 M | 2.11 M | 1.97 M | 2.12 M | 2.15 M | 2.12 M | 2.15 M | 2.14 M | 2.07 M | 2.37 M | 2.07 M | 2.39 M | 2.47 M | 2.33 M | 2.47 M | 2.19 M | 2.19 M | 2.27 M | 2.19 M | 2.71 M | 2.84 M | 2.62 M | 2.84 M | 2.64 M | 2.86 M | 2.64 M | 2.86 M | 2.56 M | 2.69 M | 2.63 M | 2.69 M | 2.63 M | 2.69 M | 2.63 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Allied Healthcare Products (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
China
Israel
Britain
Canada
